CVS Health plans to split into two public companies by the first half of 2028, the company announced Wednesday. The plan would separate its roughly 9,000 retail pharmacies from its insurance business and its pharmacy benefit manager, Caremark. CVS said the decision follows a "comprehensive strategic review" by its board of directors.

The move would reverse the $78 billion acquisition of insurer Aetna and break up the vertically integrated company it built in 2018. Shares fell roughly 11% on Wednesday, according to the report.

CEO David Joyner told CNBC's "Squawk on the Street" that the decision is "out of a position of strength." He pointed to recovery in Aetna's Medicare business and solid performance in retail pharmacy. The insurance and PBM company will keep the CVS Health name and be run by Joyner. The pharmacy company, CVS Pharmacy, will be led by Prem Shah, currently group president of CVS Health. CVS said additional leadership and board members will be announced later.

Existing shareholders will own stock in both companies. CVS also reported third-quarter earnings and revenue that topped Wall Street expectations, with total sales of $108.40 billion, up from $102.87 billion a year earlier.

Joyner said the two businesses' synergies "are going to be preserved in commercial agreements between the two organizations." Leerink Partners analyst Michael Cherny said the split reflects the stability of the pharmacy business. The report notes that pharmacy benefit managers face scrutiny from lawmakers in Washington and several states, and that Tennessee and Arkansas have passed laws banning co-ownership of PBMs and pharmacies. CVS and other companies have challenged those laws in court.